Accuray Future Growth
Future criteria checks 4/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Accuray.
Earnings growth rate
EPS growth rate
|Medical Equipment earnings growth||18.1%|
|Revenue growth rate||5.9%|
|Future return on equity||n/a|
|Last updated||28 Apr 2023|
Recent future growth updates
Earnings and Revenue Growth Forecasts
|Date||Revenue||Earnings||Free Cash Flow||Cash from Op||Avg. No. Analysts|
Analyst Future Growth Forecasts
Earnings vs Savings Rate: XEJ is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.2%).
Earnings vs Market: XEJ is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: XEJ is expected to become profitable in the next 3 years.
Revenue vs Market: XEJ's revenue (5.9% per year) is forecast to grow faster than the German market (4.3% per year).
High Growth Revenue: XEJ's revenue (5.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if XEJ's Return on Equity is forecast to be high in 3 years time